This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

American Medical Selling Unit

American Medical Systems (AMMD) agreed to sell its aesthetics division to Iridex (IRIX - Get Report) in a deal worth up to $37 million.

Iridex will pay American Medical $28 million at the close of the transaction, plus up to an additional $9 million for any remaining inventory at the end of a six- to nine-month manufacturing-transition period. The sale is expected to close no later than Jan. 31.

American Medical will use the proceeds from the sale to pay down long-term debt.

"Importantly, for the customers and the employees of our aesthetics division, Iridex is a company with a history of success in this field," said Martin Emerson, the company's president and CEO in a press release Friday. "I am further encouraged by the fact that Iridex is fully committed to building upon the reputation and relationships that have been built across the globe by our aesthetics employees."

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
IRIX $10.48 1.20%
AAPL $132.95 0.23%
FB $81.27 -0.78%
GOOG $554.24 -0.20%
TSLA $232.33 0.34%


DOW 18,100.43 +62.46 0.35%
S&P 500 2,112.82 +3.90 0.18%
NASDAQ 5,069.6710 +9.4250 0.19%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs